| |
| |
|
| Insider
Information: |
Lanchbury Jerry S |
| Relationship: |
Chief Scientific Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
264,324 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,518,230 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
264,324 |
|
|
| Total
Value |
$6,518,230 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2017-09-13 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
157,034 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2017-09-17 |
4 |
D |
$33.05 |
$227,946 |
D/D |
(6,897) |
150,137 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2017-09-30 |
4 |
D |
$36.18 |
$409,847 |
D/D |
(11,328) |
138,809 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-06-18 |
4 |
AS |
$40.12 |
$2,407,200 |
D/D |
(60,000) |
138,809 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-06-18 |
4 |
OE |
$30.12 |
$1,807,200 |
D/D |
60,000 |
141,155 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-07-11 |
4 |
OE |
$30.34 |
$1,517,000 |
D/D |
50,000 |
142,670 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-07-11 |
4 |
AS |
$43.34 |
$2,167,040 |
D/D |
(50,000) |
138,809 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-17 |
4 |
D |
$46.35 |
$301,970 |
D/D |
(6,515) |
132,294 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
182,294 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-25 |
4 |
D |
$46.65 |
$258,628 |
D/D |
(5,544) |
176,750 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-30 |
4 |
D |
$46.00 |
$492,246 |
D/D |
(10,701) |
166,049 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
38,000 |
203,899 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2019-09-25 |
4 |
D |
$29.93 |
$292,057 |
D/D |
(9,758) |
194,141 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2019-09-30 |
4 |
D |
$28.63 |
$306,370 |
D/D |
(10,701) |
183,440 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,068 |
193,508 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2020-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,800 |
226,308 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2020-09-25 |
4 |
D |
$12.44 |
$121,390 |
D/D |
(9,758) |
216,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2020-09-26 |
4 |
D |
$12.44 |
$45,120 |
D/D |
(3,627) |
212,923 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2020-09-30 |
4 |
D |
$13.04 |
$72,294 |
D/D |
(5,544) |
207,379 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
39,196 |
246,575 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
AS |
$29.71 |
$2,377,048 |
D/D |
(80,000) |
246,575 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
OE |
$18.00 |
$1,440,000 |
D/D |
80,000 |
252,130 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,347 |
265,922 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-04-27 |
4 |
OE |
$19.47 |
$778,800 |
D/D |
40,000 |
305,922 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-04-27 |
4 |
AS |
$31.47 |
$1,258,800 |
D/D |
(40,000) |
265,922 |
0 |
% |
|
140 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
